ReviewNational science review2025
Closing the loop: autonomous intelligent control for hypoxia pre-acclimatization and high-altitude health management.
Review in National science review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The role of PaCO₂ in high-altitude pre-acclimatization.National science review · 2025Article
- Mechanisms of ventilatory acclimatization to high altitude.National science review · 2025Article
- Unraveling the complexity of cognitive impairment following high-altitude exposure: from preclinical animal models to human organoids.Frontiers in neuroscience · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypobaric hypoxia at high altitudes threatens the health of high-altitude residents. The development of effective methods to guarantee the safety of frequent human activities in high-altitude locations is therefore needed. Pre-acclimatization at sea level is an effective approach to mitigate subsequent altitude sickness for rapid ascent, which offers a viable substitute to on-site acclimatization, minimizes the associated risks that are linked to prolonged exposure in high-altitude environments and can be personalized to individual hypoxic responses. Another critical aspect to prevent long-term physical damage is personalized health management at high altitudes, which is enabled by the emerging technologies of wearable sensors, the Internet of Medical Things and artificial intelligence. In this review, we outline the progress in pre-acclimatization and high-altitude health management, as well as the understanding of physiological mechanisms under hypoxia, highlighting the important role that is played by wearable sensors and physiological closed-loop control systems in developing intelligent personalized solutions. We also discuss the challenges and prospects of deploying autonomous intelligent monitoring and control in high-altitude health management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.